KARYOPHARM THERAPEUTICS INC NASDAQ:​KPTI

Recently FDA released data suggesting KPTI and myloma medicationi was too "Toxic" their MM chemo drug had SERIOUS toxicity AEs and even DEATH. Cohort of 123 pts ~86% had some sort of serious AE and ~24% dropped out because of this. to find out more about what happened and why SP dropped, see synopsis in the link below. Synopsis of Data can be found here- opening...

a break inbetween the triangle, could lead to a breakout to higher levels

KPTI: karyopharm therapeut 2018-04-30 16:05:08 Detected possible positive results in drug trial

Many indications of long entry. Scaling in off intra-day trend.

GO

Long but first wait the pullback. long >10.22 stop 9.99 target 11.50

nice chart and news